Geode Capital Management LLC Acquires 84,889 Shares of agilon health, inc. (NYSE:AGL)

Geode Capital Management LLC boosted its stake in agilon health, inc. (NYSE:AGL) by 1.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,893,517 shares of the company’s stock after acquiring an additional 84,889 shares during the period. Geode Capital Management LLC’s holdings in agilon health were worth $27,097,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of agilon health in the 3rd quarter worth about $28,000. City State Bank purchased a new stake in agilon health in the third quarter worth about $52,000. Allspring Global Investments Holdings LLC boosted its position in agilon health by 17,790.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after acquiring an additional 10,674 shares in the last quarter. Signaturefd LLC grew its holdings in shares of agilon health by 166.2% during the 2nd quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after acquiring an additional 7,398 shares during the period. Finally, CIBC Asset Management Inc purchased a new position in shares of agilon health during the 2nd quarter worth approximately $78,000.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. JMP Securities cut agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a research report on Wednesday, October 2nd. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Citigroup dropped their price objective on shares of agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research note on Wednesday, November 13th. Finally, Evercore ISI decreased their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Three research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $4.28.

agilon health Trading Down 1.0 %

agilon health stock opened at $1.89 on Friday. agilon health, inc. has a one year low of $1.50 and a one year high of $13.28. The business’s fifty day moving average is $2.20 and its 200 day moving average is $4.12. The stock has a market capitalization of $778.71 million, a PE ratio of -2.01 and a beta of 0.51. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the prior year, the firm earned ($0.06) earnings per share. On average, sell-side analysts predict that agilon health, inc. will post -0.52 EPS for the current year.

Insider Buying and Selling at agilon health

In other agilon health news, Director Diana Mckenzie acquired 12,500 shares of the stock in a transaction dated Monday, November 25th. The shares were purchased at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the purchase, the director now directly owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. This trade represents a 32.20 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Karen Mcloughlin bought 25,000 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The shares were acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. This trade represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 90,000 shares of company stock worth $198,100. Insiders own 3.20% of the company’s stock.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.